Annual EBIT:
-$256.18M+$120.56M(+32.00%)Summary
- As of today, TVTX annual earnings before interest & taxes is -$256.18 million, with the most recent change of +$120.56 million (+32.00%) on December 31, 2024.
- During the last 3 years, TVTX annual EBIT has fallen by -$116.68 million (-83.64%).
- TVTX annual EBIT is now -36597614.29% below its all-time high of -$700.00, reached on February 28, 2011.
Performance
TVTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$12.65M+$30.02M(+70.36%)Summary
- As of today, TVTX quarterly earnings before interest & taxes is -$12.65 million, with the most recent change of +$30.02 million (+70.36%) on June 30, 2025.
- Over the past year, TVTX quarterly EBIT has increased by +$54.40 million (+81.13%).
- TVTX quarterly EBIT is now -6325100.00% below its all-time high of $200.00, reached on February 1, 2009.
Performance
TVTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$170.68M+$54.40M(+24.17%)Summary
- As of today, TVTX TTM earnings before interest & taxes is -$170.68 million, with the most recent change of +$54.40 million (+24.17%) on June 30, 2025.
- Over the past year, TVTX TTM EBIT has increased by +$145.56 million (+46.03%).
- TVTX TTM EBIT is now -42670900.00% below its all-time high of -$400.00, reached on May 1, 2008.
Performance
TVTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TVTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +32.0% | +81.1% | +46.0% |
| 3Y3 Years | -83.6% | +79.1% | +7.4% |
| 5Y5 Years | -156.7% | +32.8% | -147.0% |
TVTX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -83.6% | +32.0% | at high | +86.3% | at high | +51.9% |
| 5Y | 5-Year | -239.9% | +32.0% | at high | +86.3% | -147.0% | +51.9% |
| All-Time | All-Time | >-9999.0% | +32.0% | >-9999.0% | +86.3% | >-9999.0% | +51.9% |
TVTX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$12.65M(+70.4%) | -$170.68M(+24.2%) |
| Mar 2025 | - | -$42.67M(+28.1%) | -$225.09M(+12.1%) |
| Dec 2024 | -$256.18M(+32.0%) | -$59.33M(-5.9%) | -$256.18M(+8.4%) |
| Sep 2024 | - | -$56.03M(+16.4%) | -$279.69M(+11.6%) |
| Jun 2024 | - | -$67.05M(+9.1%) | -$316.25M(+5.6%) |
| Mar 2024 | - | -$73.77M(+10.9%) | -$334.94M(+4.6%) |
| Dec 2023 | -$376.74M(-17.8%) | -$82.84M(+10.5%) | -$350.93M(+1.1%) |
| Sep 2023 | - | -$92.58M(-8.0%) | -$354.80M(-2.9%) |
| Jun 2023 | - | -$85.74M(+4.5%) | -$344.82M(-7.9%) |
| Mar 2023 | - | -$89.77M(-3.5%) | -$319.62M(-11.4%) |
| Dec 2022 | -$319.81M(-129.2%) | -$86.70M(-5.0%) | -$286.90M(-15.2%) |
| Sep 2022 | - | -$82.60M(-36.4%) | -$249.09M(-35.1%) |
| Jun 2022 | - | -$60.54M(-6.1%) | -$184.33M(-17.0%) |
| Mar 2022 | - | -$57.05M(-16.7%) | -$157.59M(-13.0%) |
| Dec 2021 | -$139.50M(-85.1%) | -$48.89M(-173.9%) | -$139.50M(-20.4%) |
| Sep 2021 | - | -$17.85M(+47.2%) | -$115.83M(-3.1%) |
| Jun 2021 | - | -$33.81M(+13.2%) | -$112.33M(-15.4%) |
| Mar 2021 | - | -$38.96M(-54.5%) | -$97.35M(-29.2%) |
| Dec 2020 | -$75.38M(+24.5%) | -$25.21M(-75.7%) | -$75.38M(-9.1%) |
| Sep 2020 | - | -$14.35M(+23.8%) | -$69.10M(+7.7%) |
| Jun 2020 | - | -$18.82M(-10.8%) | -$74.89M(+16.1%) |
| Mar 2020 | - | -$16.99M(+10.3%) | -$89.24M(+10.6%) |
| Dec 2019 | -$99.81M(-45.3%) | -$18.94M(+6.0%) | -$99.81M(-3.3%) |
| Sep 2019 | - | -$20.14M(+39.3%) | -$96.66M(-1.2%) |
| Jun 2019 | - | -$33.18M(-20.4%) | -$95.50M(-16.9%) |
| Mar 2019 | - | -$27.56M(-74.6%) | -$81.72M(-19.4%) |
| Dec 2018 | -$68.69M(-143.9%) | -$15.78M(+16.9%) | -$68.45M(-18.2%) |
| Sep 2018 | - | -$18.98M(+2.2%) | -$57.89M(-31.7%) |
| Jun 2018 | - | -$19.40M(-35.8%) | -$43.96M(-26.1%) |
| Mar 2018 | - | -$14.29M(-173.5%) | -$34.87M(-10.2%) |
| Dec 2017 | -$28.17M | -$5.22M(-3.5%) | -$31.65M(+14.5%) |
| Sep 2017 | - | -$5.05M(+51.1%) | -$37.00M(+11.6%) |
| Jun 2017 | - | -$10.31M(+6.8%) | -$41.86M(-4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$11.06M(-4.6%) | -$40.14M(-15.9%) |
| Dec 2016 | -$34.62M(-7.3%) | -$10.58M(-6.8%) | -$34.62M(-6.6%) |
| Sep 2016 | - | -$9.90M(-15.3%) | -$32.49M(-3.3%) |
| Jun 2016 | - | -$8.59M(-54.9%) | -$31.47M(-5.9%) |
| Mar 2016 | - | -$5.55M(+34.4%) | -$29.70M(+7.9%) |
| Dec 2015 | -$32.26M(+59.6%) | -$8.45M(+4.8%) | -$32.26M(+24.1%) |
| Sep 2015 | - | -$8.88M(-30.1%) | -$42.51M(+25.5%) |
| Jun 2015 | - | -$6.82M(+15.8%) | -$57.07M(+19.3%) |
| Mar 2015 | - | -$8.10M(+56.7%) | -$70.75M(+10.8%) |
| Dec 2014 | -$79.81M(-222.2%) | -$18.70M(+20.2%) | -$79.30M(-9.4%) |
| Sep 2014 | - | -$23.44M(-14.3%) | -$72.47M(-34.5%) |
| Jun 2014 | - | -$20.50M(-23.1%) | -$53.88M(-48.9%) |
| Mar 2014 | - | -$16.65M(-40.3%) | -$36.19M(-66.1%) |
| Dec 2013 | -$24.77M(+18.1%) | -$11.87M(-144.6%) | -$21.79M(+45.7%) |
| Sep 2013 | - | -$4.85M(-72.4%) | -$40.17M(-13.7%) |
| Jun 2013 | - | -$2.82M(-25.1%) | -$35.31M(-8.7%) |
| Mar 2013 | - | -$2.25M(+92.6%) | -$32.50M(-7.4%) |
| Dec 2012 | -$30.26M(>-9900.0%) | -$30.25M(>-9900.0%) | -$30.25M(>-9900.0%) |
| Nov 2011 | - | $0.00(0.0%) | -$600.00(+14.3%) |
| Aug 2011 | - | $0.00(0.0%) | -$700.00(0.0%) |
| May 2011 | - | $0.00(+100.0%) | -$700.00(0.0%) |
| Feb 2011 | -$700.00(+53.3%) | -$600.00(-500.0%) | -$700.00(-40.0%) |
| Nov 2010 | - | -$100.00(>-9900.0%) | -$500.00(-25.0%) |
| Aug 2010 | - | $0.00(0.0%) | -$400.00(+20.0%) |
| May 2010 | - | $0.00(+100.0%) | -$500.00(+66.7%) |
| Feb 2010 | -$1500.00(-7.1%) | -$400.00(>-9900.0%) | -$1500.00(-66.7%) |
| Nov 2009 | - | $0.00(+100.0%) | -$900.00(+57.1%) |
| Aug 2009 | - | -$100.00(+90.0%) | -$2100.00(-5.0%) |
| May 2009 | - | -$1000.00(-600.0%) | -$2000.00(-42.9%) |
| Feb 2009 | -$1400.00(+97.3%) | $200.00(+116.7%) | -$1400.00(+12.5%) |
| Nov 2008 | - | -$1200.00(>-9900.0%) | -$1600.00(-300.0%) |
| Aug 2008 | - | $0.00(+100.0%) | -$400.00(0.0%) |
| May 2008 | - | -$400.00 | -$400.00 |
| Feb 2008 | -$52.00K | - | - |
FAQ
- What is Travere Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. annual EBIT year-on-year change?
- What is Travere Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Travere Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Travere Therapeutics, Inc.?
- What is Travere Therapeutics, Inc. TTM EBIT year-on-year change?
What is Travere Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of TVTX is -$256.18M
What is the all-time high annual EBIT for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$700.00
What is Travere Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, TVTX annual earnings before interest & taxes has changed by +$120.56M (+32.00%)
What is Travere Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of TVTX is -$12.65M
What is the all-time high quarterly EBIT for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $200.00
What is Travere Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, TVTX quarterly earnings before interest & taxes has changed by +$54.40M (+81.13%)
What is Travere Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of TVTX is -$170.68M
What is the all-time high TTM EBIT for Travere Therapeutics, Inc.?
Travere Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$400.00
What is Travere Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, TVTX TTM earnings before interest & taxes has changed by +$145.56M (+46.03%)